PriceTargets.com logo

Dr. Martens - DOCMF Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 4
  • Breakdown:
  • 0 Sell Ratings
  • 4 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$1.24 As of 12/1/2023 09:55 PM ET
▲ +0.09 (7.83%)

This chart shows the closing price for DOCMF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Dr. Martens Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for DOCMF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for DOCMF

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 4 analysts offering 12 month price targets for Dr. Martens in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $1.24.

This chart shows the closing price for DOCMF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 4 contributing investment analysts is to hold stock in Dr. Martens. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
6/12/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
9/10/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
12/9/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
3/9/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
6/7/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
9/5/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
11/4/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
12/4/2023

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
6/12/2023Royal Bank of CanadaLower TargetGBX 180 ➝ GBX 150
6/6/2023Peel HuntDowngradeHold
6/5/2023BarclaysLower TargetGBX 210 ➝ GBX 175
5/30/2023Royal Bank of CanadaDowngradeOutperform ➝ Sector Perform
4/17/2023Royal Bank of CanadaLower TargetGBX 240 ➝ GBX 230
4/6/2023Royal Bank of CanadaLower TargetGBX 250 ➝ GBX 240
2/17/2023BarclaysLower TargetGBX 270 ➝ GBX 195
1/25/2023HSBCDowngradeBuy ➝ Hold
1/23/2023The Goldman Sachs GroupDowngradeBuy ➝ Neutral
1/20/2023Morgan StanleyLower TargetGBX 226 ➝ GBX 205
11/28/2022BarclaysLower TargetGBX 375 ➝ GBX 270
11/25/2022Morgan StanleyLower TargetGBX 276 ➝ GBX 250
6/15/2022Royal Bank of CanadaBoost TargetGBX 375 ➝ GBX 380
4/13/2022BarclaysLower TargetGBX 480 ➝ GBX 360
2/7/2022Peel HuntUpgradeHold
12/1/2021BarclaysUpgradeEqual Weight ➝ Overweight
7/12/2021The Goldman Sachs GroupUpgradeNeutral ➝ Buy
6/28/2021HSBCUpgradeHold ➝ Buy
6/21/2021Royal Bank of CanadaReiterated RatingOutperform
3/12/2021HSBCInitiated CoverageHold
3/11/2021BarclaysInitiated CoverageEqual Weight
3/11/2021Royal Bank of CanadaInitiated CoverageOutperform
3/11/2021Bank of AmericaInitiated CoverageBuy
2/10/2021Peel HuntInitiated CoverageHold
(Data available from 12/4/2018 forward)

News Sentiment Rating

0.36 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
5/8/2023
  • 2 very positive mentions
  • 10 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
6/7/2023
  • 1 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
7/7/2023
  • 1 very positive mentions
  • 8 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
8/6/2023
  • 2 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
Mentions as of
9/5/2023
  • 1 very positive mentions
  • 9 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
Mentions as of
10/5/2023
  • 2 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/4/2023
  • 5 very positive mentions
  • 14 positive mentions
  • 4 negative mentions
  • 0 very negative mentions
Mentions as of
12/4/2023

Current Sentiment

  • 5 very positive mentions
  • 14 positive mentions
  • 4 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

Dr. Martens logo
Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It offers originals, fusion, kids, and casual, as well as accessories. The company offers its products under the Dr. Martens brand name. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.
Read More

Today's Range

Now: $1.24
Low: $1.22
High: $1.25

50 Day Range

MA: $1.52
Low: $1.15
High: $1.84

52 Week Range

Now: $1.24
Low: $1.09
High: $2.65

Volume

40,300 shs

Average Volume

14,566 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Dr. Martens?

The following equities research analysts have issued reports on Dr. Martens in the last year: Barclays PLC, HSBC Holdings plc, Morgan Stanley, Peel Hunt, Royal Bank of Canada, and The Goldman Sachs Group, Inc..
View the latest analyst ratings for DOCMF.

What is the current price target for Dr. Martens?

0 Wall Street analysts have set twelve-month price targets for Dr. Martens in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Dr. Martens in the next year.
View the latest price targets for DOCMF.

What is the current consensus analyst rating for Dr. Martens?

Dr. Martens currently has 4 hold ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in DOCMF, but not buy more shares or sell existing shares.
View the latest ratings for DOCMF.

What other companies compete with Dr. Martens?

Other companies that are similar to Dr. Martens include adidas, American Rebel, ASICS, Geox and Puma. Learn More about companies similar to Dr. Martens.

How do I contact Dr. Martens' investor relations team?

Dr. Martens' physical mailing address is 28 Jamestown Road, Camden, London NW1 7BY, United Kingdom. The company's listed phone number is 44-12-1415-7047. The official website for Dr. Martens is www.drmartensplc.com. Learn More about contacing Dr. Martens investor relations.